Cargando…
Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
BACKGROUND: Persistent significant proteinuria has been associated with increased risk of progression to end-stage kidney disease in patients with idiopathic membranous nephropathy (IMN). Rituximab (RTX) therapy has given encouraging results in IMN, but most of the studies have used a higher dose, w...
Autores principales: | Bagchi, Soumita, Subbiah, Arun Kumar, Bhowmik, Dipankar, Mahajan, Sandeep, Yadav, Raj Kanwar, Kalaivani, Mani, Singh, Geetika, Dinda, Amit, Kumar Agarwal, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007352/ https://www.ncbi.nlm.nih.gov/pubmed/29942496 http://dx.doi.org/10.1093/ckj/sfx105 |
Ejemplares similares
-
The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients
por: Bagchi, Soumita, et al.
Publicado: (2022) -
Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021) -
Utility and patient acceptance of telemedicine in nephrology
por: George, Kristin, et al.
Publicado: (2022) -
Clinical Profile of Nonproteinuric Kidney Disease in Type 2 Diabetic Patients in India
por: Sangha, Sukhwinder, et al.
Publicado: (2023) -
Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)